Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,544 | 61,834 | 127,677 | 39,502 | 39,711 |
| Marketable Securities | 84,949 | 78,566 | 15,998 | 13,749 | 14,841 |
| Other current assets | 251 | 64 | 415 | 497 | 524 |
| TOTAL | $137,744 | $140,463 | $144,091 | $53,748 | $55,076 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 240 | 255 | 107 | 118 | 9 |
| TOTAL | $240 | $255 | $107 | $118 | $9 |
| Total Assets | $137,984 | $140,718 | $144,197 | $53,866 | $55,085 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,458 | 2,735 | 2,569 | 1,584 | 1,492 |
| TOTAL | $2,458 | $2,735 | $2,569 | $1,584 | $1,492 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 132 | 155 | 71 | 80 | 0 |
| TOTAL | $132 | $155 | $71 | $80 | $N/A |
| Total Liabilities | $2,589 | $2,890 | $2,639 | $1,664 | $1,492 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,699 | 6,692 | 6,683 | 6,170 | 6,115 |
| Common Shares | 7 | 7 | 7 | 6 | 6 |
| Retained earnings | -93,403 | -89,510 | -84,309 | -80,871 | -78,418 |
| Other shareholders' equity | 99 | 131 | 12 | 78 | -22 |
| TOTAL | $135,394 | $137,828 | $141,558 | $52,202 | $53,593 |
| Total Liabilities And Equity | $137,984 | $140,718 | $144,197 | $53,866 | $55,085 |